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Abstract 
Background: The fertility performance of animals is still a mystery and the full comprehension of mammalian gam-
etes maturation and early embryonic development remains to be elucidated. The recent development in nanotech-
nology offers a new opportunity for real-time study of reproductive cells in their physiological environments. As a first 
step toward that goal, we evaluated the effectiveness of a fluorescent and luminescent nanoparticle for in vitro and 
ex vivo imaging of porcine gametes.
Methods: Freshly harvested boar sperm were labeled with red-shifted (655 nm) quantum dot nanoparticles conju-
gated (QD+) or not (QD−) with plasminogen antibody and evaluated. Subsets of labeled spermatozoa were loaded 
into straws and placed within the lumen of gilt reproductive tracts for ex vivo intra-uterine imaging. Porcine cumulus-
oocyte complexes (COCs) were matured in the presence of QD− or QD+. Ovarian follicles were microinjected with 
QD− or QD+ and placed in culture for up to 4 days. After labeling, all samples were supplemented with coelentera-
zine, the luciferase substrate, and immediately submitted to bioluminescence analysis, followed by fluorescence and 
hyperspectral imaging. Data were analyzed with ANOVA and P < 0.05 indicated significant differences.
Results: All labeled-samples revealed bioluminescence emission that was confirmed by fluorescence and hyper-
spectral imaging of the QD localization within the cells and tissues. Over 76% of spermatozoa and both immature 
and mature COCs were successfully labeled with QD− or QD+. The QD− fluorescence appeared homogenously 
distributed in the oocytes, while found in the entire sperm length with a higher accumulation within the mid-piece. 
Labeled-follicles exhibited a progressive migration of QD nanoparticles within the follicle wall during culture. In con-
trast, QD+ fluorescence signals appeared condensed and stronger in the follicle cells, sperm head, and sub-plasma 
membrane area of mature oocytes. Weaker QD+ signals were detected in the cumulus cells. Fluorescence and hyper-
spectral microscope imaging showed comparable intracellular QD localization. Ex-vivo intra-uterine bioluminescence 
imaging of labeled spermatozoa revealed stronger signals captured over the oviducts, with uterine body allowing the 
lowest signal detection.
Conclusion: Findings indicate that conjugated and non-conjugated fluorescent nanoparticles can be used for  
effective labeling of mammalian gametes for in vitro monitoring and potential in vivo targeted-imaging.
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Background
The successful reproduction in mammals is orchestrated 
by successive and complex events occurring in tissues 
that are deeply embedded in the animal body. Thus, the 
examination of mammalian gametes and embryos has 
been mainly invasive; however, the recent progress in 
imaging systems, such as the digital videomicroscopy, 
allows for non-invasive and real-time investigation of 
gametes and embryos in their physiological conditions 
[1]. The combination of these imaging systems with fluo-
rescent dyes has the potential to provide a better under-
standing of the biological and physiological processes 
related to successful reproduction. Few studies have 
attempted non-invasive imaging of spermatozoa [2, 3], 
using fiber-optic fluorescence imaging based upon the 
green fluorescence protein that is known to have tre-
mendous brightness and photo-stability limitations for 
deep-tissue imaging. These challenges can be overcome 
with fluorescent inorganic nanoparticles [4]. The recent 
progress in nanotechnology provides a new horizon to 
unfold the mystery of the multifaceted molecular net-
works that are associated with oocyte maturation and 
sperm function [5, 6].
Inorganic semi-conductor quantum dots are size-tun-
able particles of up to 10  nm in diameter. Their unique 
optical and electronic properties allow size-dependent 
emission of photo-stable and bright fluorescence, from 
ultraviolet to near infra-red [7–10]. Over the past two 
decades, the specific features of quantum dots have been 
exploited for bio-imaging in biomedical research, espe-
cially by rendering them compatible with biological flu-
ids [11–14]. Thus, the possibility to cross-linking these 
nanoparticles to various biomolecules (protein, antibody, 
peptide, DNA, etc.) has made them very attractive tools 
for non-invasive and real-time bio-imaging through cell 
labeling, single molecule or cell tracking, and diagnostic 
and targeted therapy [8, 15–17]. The attachment of pro-
teins such as luciferase makes quantum dots suitable for 
both bioluminescence and fluorescence imaging [6, 18, 
19], with the bioluminescence component serving for 
routine and rapid laboratory confirmation of labeling and 
the fluorescence part for deep tissue imaging through 
specific targets, such as protein [20].
Recently, we used luciferase-conjugated fluorescent 
quantum dots (BRET-QD) to assess their interactions 
with boar spermatozoa [5]. The QD-BRET complex is 
a self-illuminating nanoparticle that emits light under 
incubation with coelenterazine, the luciferase substrate 
[6]. This enzymatic reaction generates enough energy to 
excite the quantum dot core, leading to an intense red-
shifted fluorescence emission (655 nm) that is crucial for 
deep-tissue molecular imaging [21]. Our previous study 
using this nanoparticle complex was an attempt to build 
on this dual imaging technology to enhance our com-
prehension of the complex biological and physiologi-
cal processes of reproduction through non-invasive and 
real-time analyses [5]. In that pioneer study, we found 
that, when properly used, BRET-QD nanoparticles inter-
act with spermatozoa without impairing their motility, 
quality (integrity of plasma and mitochondrial mem-
branes), and viability (ability to fertilize the oocytes) 
characteristics.
In the present study, we expanded the potential use 
of QD-BRET nanoparticles for non-invasive imaging 
of spermatozoa within the female genital tract, while 
exploring the possibility for imaging cultured ovarian 
follicles and in vitro matured oocytes. In parallel, we 
conducted a targeted bio-imaging using the QD-BRET 
tagged with anti-porcine plasminogen antibody. In previ-
ous studies, this protein has been detected in the oocyte 
and has putative role during fertilization [22–24].
Methods
Materials and reagents
Stock solutions of coelenterazine (0.5  mg/ml metha-
nol) and CdSe/ZnS core-shell structure quantum dots 
(500 nM in Tris buffer) cross-linked to Renilla luciferase 
(BRET) and nona-arginine R9 peptide (QD-BRET) were 
purchased from Zymera Inc. (San Jose, CA, USA). Func-
tionalized QD-BRET complexes with the anti-porcine 
plasminogen antibody (PLG; cat#BP750, Acris Anti-
bodies, Inc., San Diego, CA, USA) were prepared and 
purchased from Zymera. The functionalization did not 
affect the QD-BRET fluorescence and both functional-
ized (QD+) and non-functionalized (QD−) nanoparti-
cles were used in the study. Additional, the anti-human 
plasminogen antibody was purchased from Santa Cruz 
Biotechnology (cat#25546; Santa Clara, CA, USA) for 
confirmation of the functionalized-QD-BRET labeling. 
Boar semen was purchased at a commercial boar stud 
(Prestage Farms; West Point, MS, USA) and reproduc-
tive tracts with pre-ovulatory ovaries were collected from 
post-mortem gilts. Fresh samples were transported to the 
laboratory for the purification of living spermatozoa or 
the collection of follicles and COCs. Otherwise indicated, 
all other reagents were purchased from Sigma-Aldrich 
(Saint-Louis, MO, USA). Washing medium consisted of 
a pre-warmed PBS supplemented with 1 mg/ml of PVP.
Evaluation of synthesized QD‑BRET nanoparticles
Three options were chosen to evaluate both functional-
ized (QD+) and non-functionalized nanoparticles. Ali-
quots of both QD-BRET nanoparticles were prepared 
for (1) transmission electron microscope or TEM imaging 
(Jeol 2100 Lab6 200 kV TEM operated at 200 kV), using 
a standard protocol; (2) dynamic light scattering (DLS; 
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zetaPALS @ 659  nm) diameter size measurements at 
37°C, after suspension in water and 5 min equilibration, 
and measurements (total of 5 for each nanoparticle type) 
done every 2 min using the NNLS algorithm for particle 
size; and (3) a 1% agarose gel electrophoresis, with samples 
being resolved (1X TBE buffer; 45 min at 110 V) and gels 
visualized and imaged on a UV light transilluminator.
Gamete preparation and labeling
High motile and living spermatozoa were purified by 
centrifugation (600  g for 30  min) through a monolayer 
percoll gradient (PorciPure, Nidacon; Mölndal, Swe-
den). Resulting pellets of living spermatozoa, devoid of 
any contaminations (i.e., dead/abnormal sperm, somatic 
cells, and virus and bacteria if any) were suspended in 
the washing medium and centrifuged (250g, 5  min) to 
remove the remaining percoll. Sperm pellets were resus-
pended in the washing medium, counted (SpermaCue 
Photometer; Minitube of America, Verona, WI, USA), 
and concentrations adjusted to 2 × 108 spermatozoa/ml 
of washing medium. Sperm aliquots (0.5 ml) were mixed 
with various concentrations of nanoparticles and incu-
bated for 30 min at 37°C, under a gently agitation.
Cumulus-Oocyte complexes were aspirated from 
healthy ovarian follicles, washed and transferred in four-
well dishes (Nunc; Sigma-Aldrich) containing 0.5  ml of 
maturation medium supplemented with various concen-
trations of nanoparticles. Maturation took place in an 
incubator set at 38.5°C under 5% CO2, in a humidified 
environment, as previously described [25]. After 1 h mat-
uration, groups of COCs were collected from the each 
treatment groups and considered as immature COCs. 
The remaining COCs were collected after full-term mat-
uration of 44 h.
Nanoparticles were used at concentrations of 0  nM 
QD− (QD0), 0.1  nM QD− (QD0.1−), 1  nM QD− 
(QD1−), and 1 nM QD+ (QD1+) to label both gametes. 
Concentrations of 0, 0.1, and 1 nM QD respectively cor-
responded to 0, 0.3 ×  1011, and 3 ×  1011 nanoparticles 
and all experiments were repeated four times with inde-
pendent sample collections (semen or ovaries).
Evaluation of sperm labeling and viability
Immediately after labeling, a 4 × 2 factorial arrangement 
of spermatozoa was used to evaluate the acrosome mem-
brane integrity. The four labeled-groups of spermatozoa 
(QD0, QD0.1−, QD1−, and QD1+) were incubated with 
0 or 1.5 μg/ml of FITC-PSA dye in the washing medium 
(Sigma-Aldrich) for 20  min at 37°C. After two washes 
(1,000  g—3  min) to remove the excess of dye, sperma-
tozoa were suspended in PBS. Non-labeled spermatozoa 
were incubated with 0 or 10 µM Ca2+ ionophore A23187 
(Sigma-Aldrich). The presence of ionophore served as a 
positive control to induce acrosome reaction. All sam-
ples were subjected to a flow cytometry analysis of the 
QD labeling and FITC-PSA staining. The flow cytom-
eter (Becton–Dickinson FACSDiva version 6.1.3) was 
equipped with a quantum dot 655 nm filter and a 488 nm 
argon laser excitation. The proportions of sperm labeling 
in each factorial arrangement and controls (samples with 
or without ionophore) were evaluated. Experiments were 
repeated three times with independent sample collec-
tions and a minimum of 3,000 sperm cells were analyzed 
per sample in each experimental replicate.
Tissue preparation and labeling
Ovarian follicles A protocol developed by Wu et al. was 
used with a minor modification in this study [26]. Briefly, 
healthy antral follicles (4–8  mm in diameter) were dis-
sected from pig ovaries in North Carolina State Univer-
sity-23 (NCSU-23) holding medium supplemented with 
3% BSA-Fraction V (mg/ml). Dissected and trimmed 
follicles were placed in the culture medium consisting 
of NCSU-23 medium supplemented with 3 mg/ml BSA, 
1% (v/v) Insulin-Transferrin-Selenium (ITS), 1.5  ng/ml 
porcine follicle-Stimulating hormone (pFSH), 30  ng/ml 
human Luteinizing hormone (hLH), 7.5% (v/v) porcine 
serum, and 1% (v/v) Penicillin/Streptomycin. The cul-
ture took place in 24-well tissue culture plates with 2–3 
follicles per well containing 2–3  ml of culture medium. 
After 24 h of culture at 37°C under 5% CO2, in a humidi-
fied environment, follicles were microinjected (FemtoJet 
microinjection system; Eppendorf, Hauppauge, NY, USA) 
with 5 µl of PBS or 60 pmol (in 5 µl) QD1− or QD1+  , 
and follicles were returned to culture (Day 0) for an addi-
tional 4 days (Day 4). Half of culture media was renewed 
every other day, from Day 0. Subset of follicles was not 
microinjected for later use as controls, for auto-fluores-
cence or -luminescence.
Reproductive tracts On the day of experiment, repro-
ductive tracts of gilts were freshly collected at a local 
abattoir and transported to the laboratory on ice. All gen-
ital tracts were washed several times, cut into anatomic 
sections (uterine body, uterine horn, and oviduct), and all 
sections were kept in the washing medium until use for 
imaging. One tract was used for each replicate and a total 
of three independent replicates were performed.
Bioluminescence imaging
After labeling, all groups of spermatozoa (108/0.5  ml of 
labeling medium) were washed three times by centrifuga-
tion (1,000×g-3 min) to remove the excess of nanoparti-
cles. Sperm pellets were resuspended in 50 μl of washing 
medium and kept into 1.5-ml Eppendorf tubes for in 
situ imaging. For ex vivo intra-uterine imaging, labeled 
(QD-) and unlabeled (QD0 or control) spermatozoa were 
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separately loaded into 0.5-ml plastic straws that were 
subsequently placed outside and inside the reproduc-
tive tract sections for imaging. Groups of approximately 
50 labeled and unlabeled COCs were manipulated sepa-
rately and washed three times by successive steps, fol-
lowed by their transferred into a 96-well black bottom 
plate containing 50 μl of PBS for imaging. Ovarian fol-
licles were collected on Day 1, Day 2, and Day 4 post-nan-
oparticles microinjection.
For bio-imaging, sperm suspensions and COCs were 
respectively supplemented with 4 and 2  μg of coelent-
erazine, while follicles were microinjected with 750  ng. 
All samples were immediately imaged (within 5  min) 
for bioluminescence signal or photon emission using 
the IVIS 100 imaging system (Perkin Elmer, Hopkinton, 
MA, USA), as previously reported [5]. The total photon 
emission data were recorded as photons/s. However, the 
proportion of light transmitted and captured across the 
surface of genital tract tissue sections was calculated as 
the total photon emission of luminal labeled sperma-
tozoa (Inside) divided by the total photon emission of 
labeled spermatozoa outside of the genital tract [(Inside/
Outside) × 100].
Fluorescence, hyperspectral, and transmission electron 
microscope imaging
After bioluminescence imaging, all samples were kept 
for in situ fluorescence imaging of quantum dots within 
the cells. Labeled and non-labeled samples were fixed in 
4% methanol-free paraformaldehyde (spermatozoa and 
COCs) or 10% formalin (follicles) solutions. Fixed follicles 
were submitted to histological preparation, and sections 
of 4–6 μm thickness were generated. All other samples 
were smeared or placed on histology slides, rinsed, and 
mounted with appropriate medium for imaging.
Laser fluorescence imaging was performed with the 
confocal microscope (LSM510, Carl Zeiss Micro Imaging 
GmbH, Jena, Germany). For direct imaging, anti-human 
plasminogen antibody (Santa Cruz Biotechnology) was 
used for in situ immunofluorescence detection using 
FITC-conjugated secondary antibody as previously 
described [27]. After mounting on microscope histol-
ogy slides with medium containing DAPI to counterstain 
nuclei, slides were used for confocal fluorescence imag-
ing. Microscope filter sets of 420/40 Excitation, 660/40 
Emission, and 475 DCXR dichroic were used and the 
background fluorescence of samples without nanoparti-
cles served as the control.
Optical and hyperspectral imaging were performed 
with the CytoViva® imaging technology (CytoViva Inc.; 
Auburn, AL, USA). Spatial and spectral data were col-
lected in each pixel of spermatozoa, COCs, and fol-
licle sections that were fixed on histology glass slides. 
Hyperspectral data were quantified (CytoViva Hyper-
spectral Image Analysis Software algorithm). PBS-dis-
persed quantum dot nanoparticles were used to create 
the reference spectral library by comparing the particle 
filter results to a negative control sample, which removes 
any false positive spectral data and ensures valid results. 
Dark-field optical images of samples were taken and 
scanned with the reference spectral library to match pix-
els corresponding to the nanoparticles. Matching pixels 
were mapped in a pseudo red color to illustrate the pres-
ence and location of the nanoparticles in cells.
Transmission electron microscopy was performed on 
spermatozoa only. Sperm samples previously labeled with 
functionalized (QD+) or non-functionalized (QD−) QD-
BRET were prepared for TEM as previously described 
[5]. Images were taken with the Jeol 2100 Lab6 200  kV 
TEM, operated at 200 kV.
Statistical analyses
Analyses were performed with the IBM SPSS 22.0 soft-
ware package. One way-ANOVA was used to test the 
effect of the nanoparticle labeling (fixed factor) on all 
dependent factors (bioluminescence and fluorescence 
intensities and viability data). When statistical differ-
ences were observed p  <  0.05), analyses were followed 
by pairwise comparisons (Fisher’s LSD post hoc test). 
All data are expressed as mean ± SEM, unless otherwise 
indicated.
Results and discussion
Numerous challenges associated with deep-tissue char-
acteristics drastically limit the broad application of bio-
imaging technologies in large animals [28]. Especially in 
the reproduction field, the need of high spatio-temporal 
resolution and satisfactory contrast imaging technologies 
to detect spermatozoa and perform molecular or func-
tional analyses are essential to overcome these challenges 
[1, 29]. Here we tested the interaction of QD-BRET 
(QD−) nanoparticles with pig gametes and ovarian fol-
licles, for non-targeted and targeted bio-imaging in in 
vitro (labeled-spermatozoa and -oocytes), ex vivo (intra-
uterine labeled-spermatozoa), and in situ (labeled-folli-
cles during culture) settings. Previous studies have shown 
the non-toxicity of the QD− nanoparticles on boar sper-
matozoa [5] and other somatic cells [14, 16, 20, 30], when 
used at appropriate concentrations. For targeted imaging, 
we used QD− nanoparticles that were tagged with anti-
porcine plasminogen antibody (QD+).
Plasminogen is an inactive zymogen mainly synthe-
sized by the liver and at lesser extent in other tissues 
such as testes [31, 32]. Its secretions are found in various 
extracellular fluids, including seminal plasma and ovi-
ductal fluids [33, 34]. Plasminogen can specifically bind 
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to both gametes and its conversion into the serine pro-
tease plasmin by sperm-bound urokinase-type plasmi-
nogen activators (u-PAs) contribute to the regulation of 
fertilization [22, 23, 34, 35].
Evaluation of synthesized QD‑BRET nanoparticles
All data are summarized in Figure 1. The calculated aver-
age (±SD) of random measurements of QD core–shell 
(CdSe/ZnS) diameters through the transmission elec-
tron microscopy (TEM) images was 8.2 ± 1.7 nm, which 
appeared little bit higher than our previous report [5] 
using a different batch of QD-BRET nanoparticles pre-
pared by the same company (Zymera, Inc.). The tedious-
ness of measuring quantum dot core–shells on the TEM 
may likely explain variations observed between studies. 
Both QD− and QD+ stocks were dispersed in the PBS 
(pH 7.4) solution used to label spermatozoa, for hydro-
dynamic dynamic light scattering size measurements. 
Analyses clearly showed functionalized (QD+) and non-
functionalized nanoparticles with significantly differ-
ent diameter sizes by intensity (32 ± 1.3 vs. 26 ± 1.3 nm, 
respectively; P < 0.05—t test) or by volume (40.4 ± 1.8 vs. 
32.2 ±  0.9 nm, respectively; P < 0.05—t test). Both solu-
tions showed presence of aggregates that appeared larger 
in QD− (239 ± 8.6 nm) than QD+ (153 ± 3.7 nm) sam-
ples (Additional file 1: Figure S1). The use of undispersed 
samples straight from the stocks to agarose gel electro-
phoreses confirmed the size difference of both nano-
particles. The functionalized nanoparticles (QD+) were 
heavier and slower to migrate through the gel than their 
non-functionalized counterparts (Figure  1), although we 
cannot tell whether the gel imaging is showing aggregate 
or non-aggregate sizes. The technical approaches used and 
results obtained with non-functionalized nanoparticles are 
consistent with a previous study verifying the conjugation 
of luciferase (Luc8) to quantum dot emitting at 655 nm [6].
Gamete labeling and bioluminescence imaging
Spermatozoa incubated and cumulus-oocyte complexes 
(COCs) matured in the presence of 0, 0.1, and 1  nM 
QD− showed dose-dependent like production of biolu-
minescence (light) emission (Figures 2, 3). In comparison 
Figure 1 Characterization of the designed QD-BRET nanoparticles. Nanoparticles were analyzed with transmission electron microscopy (TEM), 
dynamic light scattering (DLS), and agarose gel electrophoresis. The TEM image shows the core–shell of the quantum dot nanocrystals averaging 
8.2 ± 1.7 (SD, of 20 measurements); while the DLS measured the diameter sizes (n = 5) of the functionalized (32 ± 1.3 nm) vs. non-functionalized 
(26 ± 1.3 nm) QD-BRET that were significantly different (a, b; P < 0.05; T test). The agarose gel shows differential migration of both nanoparticles, 
with functionalized aliquots (1+ , 2+ , and 5+) being heavier and migrating slowly than their non-functionalized counterparts (1−, 2−, and 5−). 
The gel was loaded with various concentrations of nanoparticles (1, 2, and 5 nM/well, equivalent to 3 × 1011, 6 × 1011, and 15 × 1011 nanoparticles, 
respectively). A 100 base pair (bp) PCR DNA ladder (Lad.) and sperm genomic DNA (gDNA) were loaded alongside for quality control of the gel 
electrophoresis.
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Figure 2 Bioluminescence imaging (BLI) of spermatozoa. A BLI of spermatozoa labeled with 0 nM (Control), 0.1 nM (QD0.1−), and 1 nM (QD1−) 
QD-BRET. Spermatozoa labeled with QD conjugated with anti-plasminogen antibody (QD1+) are also shown. Corresponding supernatants contain-
ing excess of QD− or QD+ are also imaged (bottom tubes, hand-marked S1). All samples were mixed with coelenterazine, the luciferase substrate 
before BLI. The quantification of total signals (photons/s) is summarized in B. Data are mean ± SEM of four independent replicates, and different 
letters indicate significant difference between columns (P < 0.05; ANOVA 1).
Figure 3 Bioluminescence imaging (BLI) of cumulus oocyte complexes (COCs). A BLI of COCs matured in the presence of 0 nM (Control), 0.1 nM 
(QD0.1−), and 1 nM (QD1−) QD-BRET and 1 nM QD-BRET conjugated with anti-plasminogen antibody (QD1+). All samples were mixed with 
coelenterazine, the luciferase substrate, before BLI. The quantification of total signals (photons/s) is summarized in B. Imaging of each experimental 
replicate a included well without COCs, but filled with comparable volume of PBS as in the experimental groups to allow the evaluation of the PBS 
autofluorescence contribution to the results. Data are mean ± SEM of four independent replicates. Columns with different letters are significantly 
different (P < 0.05; ANOVA 1).
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to their respective controls, the total fluxes (photons/s) 
were increased by 59× and 223×, in spermatozoa (Fig-
ure  2) and 1.6× and 1.7×, in COCs (Figure  3) by the 
presence of 0.1 and 1 nM QD− (P < 10−4; ANOVA 1). In 
contrast, lower and higher bioluminescence signals were 
respectively observed in spermatozoa and COCs labeled 
with 1 nM QD+ than their counterparts with 1 nM QD− 
(P < 0.05; ANOVA 1).
Data with spermatozoa are in agreement with our 
previous report [5], describing interaction of QD-BRET 
(QD−) nanoparticles with boar spermatozoa without 
affecting their function (motility and fertilization). Here 
we report for the first time the incorporation of QD− by 
porcine COCs, while their interactions with function-
alized nanoparticles (QD+) indicate the presence of 
plasminogen protein in both gametes. This successful 
interaction were further confirmed through transmis-
sion electron (Additional file 2: Figure S2) and confocal 
laser (Additional file 3: Figure S3) microscopy analyses, 
showing higher accumulations of quantum dots in sper-
matozoa (TEM) that corresponded to similar area tar-
geted by anti-plasminogen antibody (the sperm head). 
Overall and despite using different sources of antibodies 
(Acris and Santa Cruz), generated images appear alike, 
which position the use of nanoparticle-based imaging 
as a viable approach for non-invasive functional analy-
ses of desired proteins, such as the plasminogen/plasmin 
system, having putative role during fertilization [22, 24]. 
The current direct and indirect (through nanoparticles) 
findings bring further confirmation of the presence of 
plasminogen on mammalian oocytes [23], while reveal-
ing its presence in spermatozoa that has not yet been 
clearly demonstrated in the literature.
Ex vivo intra‑uterine bioluminescence imaging 
of spermatozoa
Accurate and non-invasive investigations of mamma-
lian gametes in physiological conditions are limited with 
the conventional techniques and imaging approaches 
[36–39]. Consequently, the progression and behavior of 
gametes, especially spermatozoa within the female repro-
ductive tract remains a mystery. As a first step toward to 
elucidating this physiological event, the current experi-
ment was developed for a possible tracking of sperma-
tozoa through the capture of luminal sperm-emitting 
photons over the reproductive tract surface.
Bioluminescence signals (photons/s) were captured 
above background on each reproductive tract section 
(Figure 4). A higher proportion of light was transmitted 
through the oviduct section (21.5  ±  2.4%), compared 
to the uterine horn (7.2 ±  0.9%) and body (1.1 ±  0.4%) 
(P < 0.01; ANOVA 1). The low proportions of transmit-
ted lights underline the challenge of deep-tissue imaging, 
while indicating the possibility of using nanotechnology 
Figure 4 Representative intra-uterine bioluminescence imaging of labeled spermatozoa. Spermatozoa were labeled or not with 1nM QD-BRET 
(QD1−), loaded into 0.5-ml plastic straws and imaged inside and outside each reproductive tract sections. Bioluminescence emissions were 
captured ex vivo, outside (a) and on the surface of oviduct (b), uterine horn (c), and uterine body (d) sections. The ratios of outside over inside 
luminescence signals (×100) were used to express and interpret data between sections.
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approach for successful imaging of spermatozoa within 
the genital tract lumen. The current imaging was based 
upon the bioluminescence property of the QD-BRET, 
which brightness is till limited for deep tissue imaging. 
Yet, the red fluorescence capability of these nanoparticles 
remains to be exploited.
The inorganic nature of quantum dots (QD) offers a 
great potential for bright and photo-stable fluorescence 
signal to allow intra-uterine imaging of spermatozoa. 
However, the successful utilization of QD nanoparticles 
for the purposed-bio-imaging may fully rely on minia-
turized devices, such as the probe-based confocal laser 
endomicroscope (pCLE). This instrument uses light in 
the visible spectrum that should be enough to excite the 
QD nanoparticle, and provide adequate spatial resolu-
tion by the mean of flexible miniaturized fiber optic 
probes of 1.5–2.6 mm outer diameter. The pCLE is being 
used for imaging diagnoses in the clinical area [40–42], 
and has been tested for ex vivo studies of spermatozoa 
in human testicle [3] and ewe oviduct [43] using organic 
fluorochromes.
Sperm labeling and viability evaluation through flow 
cytometry
Flow cytometry is an extensively used approach to study 
a variety of single sperm attributes with high precision, 
accuracy, and low costs using fluorescence techniques 
[44]. Proportions of 64 ±  4.5%, 76 ±  4%, and 91 ±  2% 
of spermatozoa were successfully labeled with 0.1 nM 
(QD0.1−), 1.0 nM (QD1−), and QD1+ compared to 
nothing in the control or QD0 group (P < 0.05). Surpris-
ingly, the mean relative fluorescence intensities (RFI) of 
QD1− and QD1+  remained comparable, but were both 
significantly higher than those in the control and QD0.1− 
(Figure 5A; P > 0.05). We attributed this discrepancy to 
the well-known brightness fluorescence of quantum 
dots, while the co-functionalization of QD-BRET with 
luciferase (Luc8) and antibody may limit the amount of 
Luc8 per QD, leading to low bioluminescence emission. 
Nevertheless, the findings suggest that most spermatozoa 
express plasminogen protein, and the limited-expression 
on the sperm surface, mostly in the head area, may result 
in a low overall bioluminescence emission.
As for the viability of labeled spermatozoa, the intact-
ness of their acrosome membrane was evaluated. The 
control group showed a proportion of 86% of sperma-
tozoa with intact acrosome, while 85% of spermatozoa 
labeled with QD1+ versus 71% with QD1− maintained 
intact acrosome membrane (Figure  5B; P  <  0.05). This 
finding indicates the possibility of small-sized QD-BRET 
(20–25 nm) to damage the sperm acrosome membrane. 
In possible support of this speculation, a recent study 
has reported the internalization of small-sized gold 
nanoparticles (less than 10 nm) and the exclusive locali-
zation of larger nanoparticles on the plasma membranes 
of intact bovine spermatozoa [45]. In the other hand, the 
absence or reduced negative effects in the QD1+ group 
may be attributable to the bigger size of functionalized 
nanoparticles (32 vs. 26  nm to QD1−) and more likely 
to their specific interactions with plasminogen proteins 
found on the sperm surface membrane. Furthermore, the 
formation of nanoparticle aggregates are another poten-
tial sources of toxicity to cells, including spermatozoa. 
Barchanski et  al. have detected higher accumulations 
of conjugated-gold nanoparticles in the post-equatorial 
region of acrosome-reacted spermatozoa, which com-
mend for further and close investigations of quantum 
dot interactions with spermatozoa [45]. These investiga-
tions will contribute to further optimize the use of quan-
tum dots for non-invasive imaging of fully functional and 
viable spermatozoa. Great interests are expected from 
controlled-uses of nanoparticles for sperm labeling in 
assisted reproduction. Here we used a total of 3 ×  1011 
nanoparticles to label 100 million spermatozoa, corre-
sponding to 3,000 nanoparticles per sperm cell that is 
well-below the 14,000 gold nanoparticles inducing detri-
mental effects on bovine spermatozoa [46]. The current 



























Figure 5 Flow cytometry evaluations of sperm labeling and viability. 
Spermatozoa were labeled with 0 nM (Control), 0.1 nM (QD0.1−), and 
1 nM (QD1− and QD1+) nanoparticles, followed by their incubation 
with FITC-PSA to the acrosome integrity or intactness. Proportions of 
0%, 76 ± 4%, and 91 ± 2% spermatozoa were labeled with nanopar-
ticles in the Control, QD0.1, QD1−, and QD1+ groups. The mean fluo-
rescence intensities of nanoparticles-labeled spermatozoa (A) and 
proportions of spermatozoa with intact and damage acrosomes (B) 
were evaluated. Spermatozoa incubated with 0 and 10 µM calcium 
ionophore served as negative and positive controls, respectively. Col-
umns (RFI, in A and QD+ intact acrosome, in B) with different letters 
differ significantly (ANOVA-1; p < 0.05). Data are mean ± SEM of four 
independent replicates.
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major losses of motility, plasma and mitochondrial mem-
brane integrities, and fertilizing potential of pig sperma-
tozoa labeled with 1  nM QD (or QD1−), equivalent to 
3,000 nanoparticles/sperm cell [5].
Ovarian follicle labeling and bioluminescence imaging
The ovarian follicle growth is concomitant with the 
oocyte development and the formation of an intra-folli-
cular cavity surrounded with various cell types. This cav-
ity is filled with a fluid resulting from blood exudates and 
other follicular cell secretions, which dynamic concentra-
tions in molecules such as hormones and growth factors 
regulate the growth of both follicle and oocyte [47, 48].
Here, the microinjection of QD nanoparticles within 
the follicular cavity constituted an attempt to develop 
a strategy for intra-follicular imaging for biosensing and 
tracking of key molecules that intra-follicularly influ-
ences oocyte quality and viability. Figure  6 shows biolu-
minescence imaging of QD-BRET nanoparticles with 
(QD1+) or without (QD1−) the plasminogen antibody 
within the ovarian follicles. Follicles microinjected with 
QD1+ always displayed greater luminescent signals than 
those with QD1− (Figure 6; Line B in Red box vs. White 
box and Line E vs. Line D). No signals were observed in 
the control groups, consisting of follicles microinjected 
with either PBS (CTL, Line A), coelenterazine (CTL, 
Line B), or QD1− without coelenterazine (Line C). Inter-
estingly, the microinjection of QD1− or QD1+  did not 
cross-contaminate the neighboring follicle (Figure 6; Lines 
D, E). This observation is important as ovarian follicles are 
independent structures with different health and develop-
mental status, leading to the production of oocytes with 
different developmental competences. Follicles microin-
jected with QD0.1− or QD1− exhibited dose-dependent 
like light emission at all time-points (Day 1, Day 2, and 
Day 4—P < 0.05; Figure 7). Interestingly, follicles microin-
jected with QD1 + maintained the highest light emission 
throughout the culture period (P < 0.05; ANOVA-1).
Although the viability of cells was not verified, data 
suggest that self-illuminating luminescent nanoparticles 
can be used for molecular imaging of cultured follicles. 
Our finding adds to a recent study reporting a successful 
intra-follicular imaging through a transgene carrying the 
luciferase reporter gene [49]. The current work paves the 
way for further optimization of this novel non-invasive 
imaging approach that will lead to promising in situ real-
time description of the oocyte maturation and related 
intra-follicular key molecules.
Figure 6 Bioluminescence imaging of QD-BRET (QD) microinjected cultured ovarian follicles. Follicles were microinjected with QD1− or QD1+ 
during in vitro culture. Imaging was performed with follicle controls, microinjected with only PBS (Line A, CTL), QD1− (Line A, White Box), or 
QD1+ (Line A, Red Box), follicles microinjected with both coelenterazine and QD1− (Line B, White Box), or QD1+ (Line B, Red Box). The inset shows fol-
licles microinjected with coelenterazine only (Line C) or with QD1− and QD1+ , showing respective bioluminescence emissions in Lines D and E.
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Confocal fluorescence microscope imaging of the 
nanoparticle bio‑distribution
Following incubation with QD1−, the fluorescence sig-
nal appeared more diffuse on the entire spermatozoon, 
with the strongest signal being observed in the mid-
piece section (Figure  8). This cellular distribution con-
trasted with the QD1+ labeling that was mainly limited 
to the sperm head (Figure 8). This observation brings a 
direct evidence of the plasminogen protein presence in 
boar spermatozoa. The spatial distribution of QD1− and 
QD1+ fluorescence signals may contribute to explain 
the differential bioluminescence emission between both 
groups.
On the other hand, the QD1− fluorescence signal 
appeared homogenously distributed within the oocyte 
and cumulus cells, before (Figure 9c, d) and after matu-
ration (Figure 9e, f ). However, this signal appeared more 
organized in oocytes matured in presence of QD1+, 
with lesser or no signal being detected in the cumulus 
cells (Figure  9g, h). Interestingly, the invasive detection 
Figure 8 Confocal fluorescence imaging of QD-BRET labeled spermatozoa. Spermatozoa were labeled with 0 nM (control) and 1 nM plasminogen-
conjugated (QD1+) or non-conjugated (QD1−) QD-BRET nanoparticles. The control group was used for fluorescence imaging settings and was 
designated as the negative control group. These settings were used to capture the fluorescence emission (upper panel). Both fluorescence and 




































Figure 7 Quantification of ex vivo bioluminescence emission of 
ovarian follicles. Totals of 52, 28, and 32 follicles were respectively ana-
lyzed on Day 1, Day 2, and Day 4, which corresponded to 13, 7, and 8 
follicles in each labeling group (Control, QD1−, and QD1+). The day 
of QD-BRET microinjection was considered as Day 0. Data are mean 
(± SEM) of three independent replicates and statistical comparisons 
were done within days (Day 1, Day2, or Day 4). Columns with different 
letters indicate significant differences (P < 0.05; ANOVA 1).
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through antibody revealed a strong accumulation of plas-
minogen in mature versus immature oocytes (Additional 
file 3: Figure S3). Both nanoparticle-based (non-invasive) 
and direct (invasive) detection of plasminogen showed 
comparable distribution within the matured oocyte.
The bio-distribution of QD1− within the follicle 
appeared dynamic during culture. A great accumula-
tion of the QD fluorescence signal was seen on the mural 
granulosa cells that surround the follicular cavity on Day 
1 post microinjection. The signal appeared within the 
theca internal on Day 2 and then reaches the farthest 
layer of cells, the theca external, on Day 4. Interestingly, 
microinjected QD were able to penetrate the cumulus-
oocyte complex, with a higher accumulation found in the 
oocyte (Figure 10).
Overall, the fluorescence imaging brings further con-
firmation of the bioluminescence observations and 
provides direct evidence of the plasminogen protein 
presence in pig gametes and ovarian follicles. Thus, 
nanotechnology approach based on self-illuminating 
quantum dots could be used as a novel methodology 
to measure the dynamic changes in molecular events 
occurring during intra-follicular growth and maturation 
of the oocyte. In this study, it is likely that the combina-
tion of QD-BRET ±  antibody complexes with the cell-
penetrating peptide, nona arginine R9, facilitates their 
incorporation into follicular and cumulus cells, which 
likely transfer incorporated-nanoparticles to the oocyte 
through gap-junctions uniting both cell types (cumulus 
cells and oocytes). The conjugation of nanoparticles with 
cell penetrating-peptides (CPP) has been shown effec-
tive for interactions with cells, including mammalian 
gametes despite different depth of penetration efficien-
cies between CPP [45]. Our findings using a polycationic 
CPP coupled to quantum dots are in agreement with 
a recent work showing accumulation of BSA-coated 
gold nanoparticles in porcine oocytes and surrounding 
cumulus cells [50]. These authors found no detrimental 
effects of gold nanoparticles on pig oocytes and sperma-
tozoa, which is in line with our present and prior find-
ings using quantum dots [5]. It is important to mention 
that these results were obtained with comparable nano-
particle diameter sizes (20 vs. 26 ± 1.3 nm for gold and 













Figure 9 Confocal fluorescence imaging of QD-BRET (QD)-labeled cumulus-oocyte complexes (COCs). COCs were labeled with 0 nM (QD0) or with 
1 nM plasminogen-conjugated (QD1+) or non-conjugated (QD1−) QD-BRET nanoparticles. Non-labeled mature or immature COCs were used 
to set up the imaging conditions (a, b). Micrographs in the upper panel (Blue frame) show QD-BRET fluorescence signals detected in COCs labeled 
before (Immature; c, d) and after (Mature; e, f, g, h) in vitro maturation. The lower panel (Black frame) shows corresponding overlaid visible and fluo-
rescence light images. Nuclei are counterstained in blue with DAPI. The white and red arrows indicate the cumulus cells and oocytes, respectively.
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(1.24  ×  1010/COC and 1.23  ×  103/sperm cell for gold 
vs. 3  ×  1011 and 3  ×  103 for quantum dot nanoparti-
cles, respectively). Yet, numerous studies have evidenced 
that the penetration of nanoparticles into spermatozoa 
remains limited or prevented by the composition and 
status of the plasma and acrosome membranes [5, 46, 
51].
Hyperspectral fluorescence imaging of the nanoparticle 
bio‑distribution
This novel nano-scale imaging technology was used to 
further confirm the QD labeling of cells and map their 
localization. The hyperspectral fluorescence imaging 
combines digital image capturing and conventional spec-
troscopy to generate spectral signatures as a function of 
wavelength that characterizes samples. Samples with-
out labeling (negative control) showed no fluorescence 
signals (Figures 11a,  12a, d), while small aliquots of QD 
suspensions and samples labeled with QD revealed ref-
erence spectral libraries with peak emission of or near 
655  nm (Figure  11b), corresponding to the emission 
wavelength of the QD used in this study.
The fluorescence signal of QD1− was mostly detected 
in the sperm mid-piece while those from QD1+ were 
stronger and essentially located in the sperm head (Fig-
ure  11d, f ). These results corroborated with those of 
the confocal microscope. Similar fluorescence intensi-
ties were observed with the cumulus-oocyte complexes 
or COCs (Figure  12b, c) and follicles (Figure  12e, f ). In 
both sample types, the QD1+ fluorescence remained 
stronger than that of QD1−. The fluorescence signal 
ratios (QD1+/QD1−) were increased to approximately 
1.6×, in spermatozoa (Figure 11f, d) and 9.3×, in COCs 
(Figure 12b, c).
Both COCs and follicle hyperspectral fluorescence 
image intensities matched the bioluminescence data. The 
Figure 10 Fluorescence imaging of follicular micro-sections following QD-BRET (QD) labeling. The upper panel shows the intracellular progres-
sion of the fluorescence signals of QD1− nanoparticles during culture (Day 1, 2, and 4). Fluorescence signals were mainly detected in the mural 
granulosa cells, surrounding the follicular cavity, on Day 1 post microinjection. The fluorescence signal progressed into the mid-section of the follicle 
wall (theca internal cells) on Day 2, and then the entire follicle wall, including the theca external cells on Day 4. The bottom panel represents the 
corresponding overlays fluorescence and visible lights. The intra-follicular COCs also incorporated the QD1− (200×). Arrows indicate the extent of 
tissue layers (GC granulosa cells, TI theca internal, TE theca external). The white arrows show detached and stained granulosa cells within the fol-
licular antrum (FA).
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application of this novel hyperspectral imaging validates 
the traditional microscope and confocal fluorescence 
technologies. The current study represents, to the best of 
our knowledge, the first report on mammalian reproduc-
tive cells that combines both nanotechnology and hyper-
spectral fluorescence for bio-imaging. The application 
of the hyperspectral fluorescence imaging is new in the 
reproductive field, but this technology has been applied 
in various research fields of biomedicine [52], including 
cancer and Parkinson’s disease diagnoses [53, 54] and tis-
sue characterization [55].
Conclusions
The current study uses various settings (in vitro, in 
situ, and ex vivo) to assess the effectiveness of a new 
nanotechnology-based imaging approach for mamma-
lian reproductive cells. We combined traditional and 
novel imaging techniques to validate the nano-based 
labeling. The proposed-imaging technology offers the 
possibility for minimal invasive tracking of reproduc-
tive cells in their physiological environments, with the 
possibility to measure changes in cellular and molecu-
lar events that affect mammalian gamete quality. How-
ever, nanoparticle uptake by ovarian follicular cells 
and subsequent bio-imaging still need optimization in 
further experiments. Furthermore, the study confirms 
the presence of plasminogen protein in pig oocytes, 
while revealing its detection in mature spermatozoa. 
This immunopositive reactivity allows for further 
noninvasive and functional analyses of the influential 
Figure 11 Hyperspectral fluorescence imaging of QD-BRET (QD) labeled spermatozoa. Negative control spermatozoa (a) were used to remove 
false positive signals and validation of QD-BRET fluorescence spectral libraries that were captured around or near 655 nm emission wavelength, as 
indicated by the arrow (b). Hyperspectral images of spermatozoa were taken (a, c, e) followed by the comparison of all pixels with the QD1− and 
QD1+ spectral libraries (Not shown here). Pixels that matched the spectral are mapped with a pseudo-red color (arrows) illustrating the presence 
and location of QD1− (d) or QD1+ (f).
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range of plasminogen during the fertilization success 
and outcomes.
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Additional file 1: Figure S1. Dynamic Light Scattering (DSL) size meas-
urements. Self-illuminating bioluminescent resonance electronic transfer 
quantum dots emitting at 655 nm (BRET-QD) and linked to nona-Arginine 
cell-penetrating peptides (R9) were functionalized (QD+) or not (QD−) 
with plasminogen antibody. Aliquots of each sample were dispersed in 
the incubation medium (PBS, pH 7.4) and submitted to the zetaPALS oper-
ated at 659 nm wavelength for DSL measurements at 37°C after 5 min 
equilibration. Monomer and aggregate sizes are indicated in black and 
blue colors, respectively.
Additional file 2: Figure S2. Transmission Electron Microscope imaging 
of labeled spermatozoa. Cross-section heads of spermatozoa labeled with 
functionalized (blue frame) and non-functionalized (black frame) QD-BRET 
are shown. Arrows indicate the localization of quantum dot (QD) core and 
higher accumulation can be seen in functionalized, compared to non-
functionalized sections.
Additional file 3:  Figure S3. Laser confocal microscope imaging 
of labeled cumulus-oocyte complexes and spermatozoa. The black 
frame regroups cumulus-oocyte complexes labeled with anti-human 
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